JP2014514243A5 - - Google Patents

Download PDF

Info

Publication number
JP2014514243A5
JP2014514243A5 JP2013542128A JP2013542128A JP2014514243A5 JP 2014514243 A5 JP2014514243 A5 JP 2014514243A5 JP 2013542128 A JP2013542128 A JP 2013542128A JP 2013542128 A JP2013542128 A JP 2013542128A JP 2014514243 A5 JP2014514243 A5 JP 2014514243A5
Authority
JP
Japan
Prior art keywords
acid
dimethylamino
dodecyl
propionate
active compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542128A
Other languages
English (en)
Japanese (ja)
Other versions
JP6109075B2 (ja
JP2014514243A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/062579 external-priority patent/WO2012075107A2/en
Publication of JP2014514243A publication Critical patent/JP2014514243A/ja
Publication of JP2014514243A5 publication Critical patent/JP2014514243A5/ja
Application granted granted Critical
Publication of JP6109075B2 publication Critical patent/JP6109075B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542128A 2010-12-02 2011-11-30 2−(n,n−ジメチルアミノ)−プロピオン酸ドデシルの活性鏡像体 Expired - Fee Related JP6109075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41899610P 2010-12-02 2010-12-02
US61/418,996 2010-12-02
PCT/US2011/062579 WO2012075107A2 (en) 2010-12-02 2011-11-30 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate

Publications (3)

Publication Number Publication Date
JP2014514243A JP2014514243A (ja) 2014-06-19
JP2014514243A5 true JP2014514243A5 (enExample) 2015-01-22
JP6109075B2 JP6109075B2 (ja) 2017-04-05

Family

ID=46172526

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542128A Expired - Fee Related JP6109075B2 (ja) 2010-12-02 2011-11-30 2−(n,n−ジメチルアミノ)−プロピオン酸ドデシルの活性鏡像体

Country Status (20)

Country Link
US (1) US20130267562A1 (enExample)
EP (1) EP2646015B1 (enExample)
JP (1) JP6109075B2 (enExample)
KR (1) KR102004552B1 (enExample)
CN (1) CN103930105B (enExample)
AU (2) AU2011336692B2 (enExample)
BR (1) BR112013012799A8 (enExample)
CA (1) CA2817417C (enExample)
CL (1) CL2013001391A1 (enExample)
CR (1) CR20130324A (enExample)
ES (1) ES2801999T3 (enExample)
IL (1) IL226173A (enExample)
MX (1) MX2013005522A (enExample)
NZ (1) NZ609826A (enExample)
PH (1) PH12013501104A1 (enExample)
PL (1) PL2646015T3 (enExample)
RU (1) RU2679308C2 (enExample)
SG (2) SG10201803321TA (enExample)
WO (1) WO2012075107A2 (enExample)
ZA (1) ZA201304840B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014028780A2 (en) * 2012-08-15 2014-02-20 Nexmed Holdings, Inc. Antifungal compounds and methods of use
US8900625B2 (en) 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6118020A (en) * 1999-05-19 2000-09-12 Nexmed Holdings, Inc. Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
JP5160018B2 (ja) * 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
WO2005009510A2 (en) * 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
PL1670433T3 (pl) * 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
WO2005051960A2 (en) * 2003-11-22 2005-06-09 Midwest Research Laboratories, Llc Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents
RU2012153177A (ru) * 2010-05-04 2014-06-20 Нексмед Холдингс, Инк. Композиции низкомолекулярных терапевтических средств
US8900625B2 (en) * 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use

Similar Documents

Publication Publication Date Title
JP2014515013A5 (enExample)
JP2011201907A5 (enExample)
JP2010270124A5 (enExample)
JP2012255026A5 (enExample)
JP2013542247A5 (enExample)
WO2008131149A3 (en) Crystal forms of saxagliptin and processes for preparing same
JP2016516074A5 (enExample)
WO2012122340A8 (en) Soluble guanylate cyclase activators
WO2011093826A3 (en) Effervescent formulations comprising cefaclor and clavulanic acid as active agents
JP2012502037A5 (enExample)
JP2013518056A5 (enExample)
JP2013515742A5 (enExample)
JP2010509326A5 (enExample)
JP2014530801A5 (enExample)
BR112014009910A2 (pt) formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico
WO2009150118A3 (en) Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid
JP2010522710A5 (enExample)
JP2011506587A5 (enExample)
JP2009544665A5 (enExample)
JP2011046708A5 (enExample)
RU2017124487A (ru) НОВЫЙ ПЕПТИД-ИНГИБИТОР PI3Kγ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОРГАНОВ ДЫХАНИЯ
JP2014505062A5 (enExample)
JP2011251985A5 (enExample)
CA2794655A1 (en) Method for treating schizophrenia and related diseases
JP2014514243A5 (enExample)